SynBac
Traditional process scale up using baculovirus is notoriously problematic, with yields dropping progressively during scale up. SynBac™ are minimized baculoviral genomes created using modern synthetic biology techniques. The SynBac™ project aims to transform fermenter-scale baculoviral production of drug targets, and manufacturing scale production of biopharmaceuticals by creating minimal baculoviral genomes displaying exceptional DNA stability. In addition to improved DNA stability, our minimized genomes form the starting point for applications that require large DNA cargo delivery to mammalian cells, primary cells, or organs.
17th Oct 2020
Recent Posts
-
Exploring PDB Structure 9MWM and Selective Inhibitor Design
STRUCTURAL BIOLOGY • ENZYMOLOGY • DRUG DISCOVERY Neuronal Nitric Oxide Synthase (nNOS): Exploring …29th Oct 2026 -
How Does RNA Seq Work
How Does RNA Seq Work? A Complete Guide to RNA Sequencing RNA sequencing (RNA Seq) is a powerful mo …26th Oct 2026 -
Ni-IDA Spin Columns
Protein Purification Ni-IDA Spin Columns Rapid small-scale purification of polyhistidine-tagged re …23rd Oct 2026